Hillrom is a United States-based company operating within the manufacturing sector, specifically in the medical devices and equipment industry, with a focus on healthcare and hospital solutions. Established in 1929, Hillrom employs between 5,001 and 10,000 individuals and reported a revenue of approximately $3 billion. The company is involved in the development and production of innovative medical technologies aimed at improving patient care and outcomes. One notable area of research includes high-frequency chest wall oscillation (HFCWO) therapy for airway clearance, particularly for patients with cystic fibrosis. A recent study evaluated the effectiveness of Hillrom's mobile HFCWO device, the Monarch Airway Clearance System, in comparison to a standard device, The Vest Airway Clearance System. The findings indicated that the Monarch System was comparable in sputum production to the standard device while demonstrating statistically significant improvements in lung status and airway geometry. This research underscores Hillrom's commitment to advancing respiratory care technologies and enhancing therapeutic options for patients.